Your browser doesn't support javascript.
loading
Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912.
Tadori, Yoshihiro; Kitagawa, Hisashi; Forbes, Robert A; McQuade, Robert D; Stark, Arlene; Kikuchi, Tetsuro.
Affiliation
  • Tadori Y; Quests Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima, 771-0192, Japan. y_tadori@research.otsuka.co.jp
Eur J Pharmacol ; 574(2-3): 103-11, 2007 Nov 28.
Article in En | MEDLINE | ID: mdl-17692841
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Benzoxazoles / Receptors, Dopamine D2 / Quinolones / Dopamine Antagonists / Dopamine Agonists / Ergolines Limits: Animals / Humans Language: En Journal: Eur J Pharmacol Year: 2007 Document type: Article Affiliation country: Japón Country of publication: Países Bajos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Benzoxazoles / Receptors, Dopamine D2 / Quinolones / Dopamine Antagonists / Dopamine Agonists / Ergolines Limits: Animals / Humans Language: En Journal: Eur J Pharmacol Year: 2007 Document type: Article Affiliation country: Japón Country of publication: Países Bajos